Viking Therapeutics (VKTX)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from VKTX's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Viking Therapeutics's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Net income | -$55M | -$69M | -$86M | -$110M | -$360M |
| Free cash flow | — | — | — | — | — |
| EPS (diluted) | -$0.71 | -$0.90 | -$0.91 | -$1.01 | -$3.19 |
| Operating margin | — | — | — | — | — |
Superinvestors who own VKTX
From each investor's latest 13F filing (what a 13F shows). 3 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Hersh Cohen ClearBridge Investments |
Held | $17M | 0.01% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Trimmed | $9M | 0.02% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | $8M | 0.00% | Q2 2026 |
Insider buying
Open-market purchases by Viking Therapeutics's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Mar 10, 2026 | Neil William Aubuchon |
4,475 | $33.50 | $149,912 |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when VKTX trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Viking Therapeutics insiders buying the stock?
1 open-market insider purchase of VKTX in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Viking Therapeutics?
3 of the superinvestors Investingly tracks hold VKTX in their latest 13F, including Hersh Cohen, Joel Greenblatt, Cliff Asness.
Companies like Viking Therapeutics
All Healthcare stocks · Biotechnology stocks · Stock lists
Prices and ratios as of Oct 8, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.